Costal Fracture Assessment for Relief and Enhancement of Quality of Life
Launched by OSPEDALI RIUNITI TRIESTE · May 4, 2024
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Costal Fracture Assessment for Relief and Enhancement of Quality of Life," is looking into how rib fractures affect patients and their quality of life. The goal is to find ways to relieve pain and improve daily functioning for those who have experienced rib injuries. The study will track patients who receive standard care for their rib fractures to see how long they need to stay in the hospital, how well they manage pain, and if they develop any respiratory infections. The findings will help improve treatment decisions and overall care for patients, especially within the National Health Service.
To be eligible for this trial, participants need to have rib fractures, and it is open to all adults aged 65 to 74. However, individuals with cognitive impairment, chronic pain from other bone issues, or active cancer cannot participate. If you join the study, you can expect to share your experiences and contribute to understanding how to better manage rib fractures, which may lead to improved care for others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with rib fractures
- Exclusion Criteria:
- • cognitive impairment
- • chronic pain due to pathologic fractures
- • active cancer
About Ospedali Riuniti Trieste
Ospedali Riuniti Trieste is a prominent healthcare institution in Italy, dedicated to advancing medical research and improving patient care through innovative clinical trials. With a focus on multidisciplinary collaboration, the hospital provides a robust infrastructure for conducting high-quality research across various therapeutic areas. Committed to ethical standards and patient safety, Ospedali Riuniti Trieste actively engages in partnerships with academic institutions and industry leaders to foster the development of new treatments and enhance clinical outcomes. Their comprehensive approach ensures the integration of cutting-edge science with compassionate healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Trieste, Ts, Italy
Trieste, Ts, Italy
Trieste, , Italy
Trieste, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported